Examining 7 years of implementing quality management systems in medical laboratories in sub-Saharan Africa.
ISO15189
SLIPTA
SLMTA
accreditation
quality assurance
quality management system
Journal
Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
pubmed:
9
12
2022
medline:
8
2
2023
entrez:
8
12
2022
Statut:
ppublish
Résumé
Achievement of ISO15189 accreditation demonstrates competency of a laboratory to conduct testing. Three programmes were developed to facilitate achievement of accreditation in low- and middle-income countries: Strengthening Laboratory Management Towards Accreditation (SLMTA), Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) and Laboratory Quality Stepwise Implementation (LQSI). To determine the level of accreditation and associated barriers and facilitators among medical laboratories in the WHO-AFRO region by 2020. A desk review of SLIPTA and SLMTA databases was conducted to identify ISO15189-accredited medical laboratories between January 2013 and December 2020. Data on access to the LQSI tool were extracted from the WHO database. Facility and country characteristics were collected for analysis as possible enablers of accreditation. The chi-square test was used to analyse differences with level of significance set at <0.05. A total of 668 laboratories achieved accreditation by 2020 representing a 75% increase from the number in 2013. Accredited laboratories were mainly in South Africa (n = 396; 55%) and Kenya (n = 106; 16%), two countries with national accreditation bodies. About 16.9% (n = 113) of the accredited laboratories were registered for the SLIPTA programme and 26.6% (n = 178) for SLMTA. Approximately 58,217 LQSI users were registered by December 2020. Countries with a higher UHC index for access to HIV care and treatment, higher WHO JEE scores for laboratory networks, a larger number of registered LQSI users, with national laboratory policy/strategic plans and PEPFAR-priority countries were more likely to have an accredited laboratory. Of the 475 laboratories engaged in the SLIPTA programme, 154 attained ≥4 SLIPTA stars (ready to apply for accreditation) and 113 achieved ISO 15189 accreditation, with 96 enrolled into the SLMTA programme. Lower-tier laboratories were less likely to achieve accreditation than higher-tier laboratories (7.7% vs. 30%) (p < 0.001). The probability of achieving ISO 15189 accreditation (19%) was highest during the first 24 months after enrolment into the SLIPTA programme. To sustainably anchor quality improvement initiatives at facility level, national approaches including access to a national accreditation authority, adoption of national quality standards and regulatory frameworks are required.
Sections du résumé
BACKGROUND
Achievement of ISO15189 accreditation demonstrates competency of a laboratory to conduct testing. Three programmes were developed to facilitate achievement of accreditation in low- and middle-income countries: Strengthening Laboratory Management Towards Accreditation (SLMTA), Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) and Laboratory Quality Stepwise Implementation (LQSI).
OBJECTIVE
To determine the level of accreditation and associated barriers and facilitators among medical laboratories in the WHO-AFRO region by 2020.
METHODS
A desk review of SLIPTA and SLMTA databases was conducted to identify ISO15189-accredited medical laboratories between January 2013 and December 2020. Data on access to the LQSI tool were extracted from the WHO database. Facility and country characteristics were collected for analysis as possible enablers of accreditation. The chi-square test was used to analyse differences with level of significance set at <0.05.
RESULTS
A total of 668 laboratories achieved accreditation by 2020 representing a 75% increase from the number in 2013. Accredited laboratories were mainly in South Africa (n = 396; 55%) and Kenya (n = 106; 16%), two countries with national accreditation bodies. About 16.9% (n = 113) of the accredited laboratories were registered for the SLIPTA programme and 26.6% (n = 178) for SLMTA. Approximately 58,217 LQSI users were registered by December 2020. Countries with a higher UHC index for access to HIV care and treatment, higher WHO JEE scores for laboratory networks, a larger number of registered LQSI users, with national laboratory policy/strategic plans and PEPFAR-priority countries were more likely to have an accredited laboratory. Of the 475 laboratories engaged in the SLIPTA programme, 154 attained ≥4 SLIPTA stars (ready to apply for accreditation) and 113 achieved ISO 15189 accreditation, with 96 enrolled into the SLMTA programme. Lower-tier laboratories were less likely to achieve accreditation than higher-tier laboratories (7.7% vs. 30%) (p < 0.001). The probability of achieving ISO 15189 accreditation (19%) was highest during the first 24 months after enrolment into the SLIPTA programme.
CONCLUSION
To sustainably anchor quality improvement initiatives at facility level, national approaches including access to a national accreditation authority, adoption of national quality standards and regulatory frameworks are required.
Identifiants
pubmed: 36480459
doi: 10.1111/tmi.13839
pmc: PMC10108081
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
126-135Informations de copyright
© 2022 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
Références
Am J Clin Pathol. 2010 Sep;134(3):393-400
pubmed: 20716795
Afr J Lab Med. 2014;3(2):216
pubmed: 26753130
Afr J Lab Med. 2022 May 31;11(1):1614
pubmed: 35747559
Afr J Lab Med. 2014;3(3):
pubmed: 26752335
Am J Clin Pathol. 2009 Jun;131(6):774
pubmed: 19461081
Am J Clin Pathol. 2010 Sep;134(3):359-60
pubmed: 20716789
Am J Clin Pathol. 2010 Sep;134(3):401-9
pubmed: 20716796
Afr J Lab Med. 2014;3(2):239
pubmed: 27453824
Am J Clin Pathol. 2010 Oct;134(4):550-5
pubmed: 20855635
Trop Med Int Health. 2023 Feb;28(2):126-135
pubmed: 36480459
Am J Clin Pathol. 2014 Jun;141(6):791-5
pubmed: 24838322
Afr J Lab Med. 2020 Sep 21;9(2):1103
pubmed: 33102173
Afr J Lab Med. 2016 May 20;5(1):280
pubmed: 28879103